Why Investors Should Watch Zynerba Pharmaceuticals Inc
Cannabis stocks are having a rough go right now, with even some of the most profitable pot stocks taking a hit. So it's probably not a surprise to learn that shares of one of the most promising clinical-stage cannabis companies, Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE), have been taking.
Den vollständigen Artikel lesen ...